MYC and neuroblastoma: MYCN-amplified NB is highly correlated with advanced disease stage and poor prognosis, which accounts for 20–25% of overall and 40% of high-risk cases [2] and MYCN-nonamplified NB with elevated c-MYC expression is also associated with a poor prognosis in NB [3].